Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,979,798 papers from all fields of science
Search
Sign In
Create Free Account
neotame
Known as:
N-(N-(3,3-dimethylbutyl)-L-alpha-aspartyl)-L-phenylalanine 1-methyl ester
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Dipeptides
Zolpidem tartrate 5 MG/ACTUAT Oral Spray [Zolpimist]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Effect of Ethanol on Interactions of Bitter and Sweet Tastes in Aqueous Solutions
Z. Panovská
,
A. Šedivá
,
Markéta Jedelska
,
J. Pokorný
2018
Corpus ID: 59493088
Experimental samples simulated the composition of vermouths. In all experiments, 0.01% quinine was used as a standard bitter…
Expand
2010
2010
Determination of neotame in beverages, cakes and preserved fruits by column-switching high-performance liquid chromatography
Dajin Yang
,
Bo Chen
Food Additives and Contaminants Part A-chemistry…
2010
Corpus ID: 11427729
A column-switching HPLC method for the determination of neotame in beverages, cakes and preserved fruits was developed. After pre…
Expand
2008
2008
Scientific Opinion of the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food
F. Aguilar
,
H. Autrup
,
+15 authors
P. Tobback
2008
Corpus ID: 31286739
SUMMARY Following a request from the Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in…
Expand
2008
2008
[Simultaneous determination of neotame, alitame and aspartame in foods by HPLC].
H. Matsumoto
,
K. Hirata
,
Narue Sakamaki
,
K. Hagino
,
H. Ushiyama
Shokuhin eiseigaku zasshi. Journal of the Food…
2008
Corpus ID: 23368684
Simultaneous determination of three artificial sweeteners, neotame (NE), alitame (AL) and aspartame (APM) in various foods by…
Expand
Highly Cited
2005
Highly Cited
2005
Quantitation of crystalline and amorphous forms of anhydrous neotame using 13C CPMAS NMR spectroscopy.
Thomas J Offerdahl
,
Jonathon S. Salsbury
,
+6 authors
E. Munson
Journal of Pharmacy and Science
2005
Corpus ID: 6568682
Although most drugs are formulated in the crystalline state, amorphous or other crystalline forms are often generated during the…
Expand
2004
2004
Crystal Structure of Neotame Anhydrate Polymorph G
Zedong Dong
,
V. Young
,
+4 authors
D. Grant
Pharmaceutical Research
2004
Corpus ID: 8267530
AbstractPurpose. To determine the crystal structure of the neotame anhydrate polymorph G and to evaluate X-ray powder…
Expand
2002
2002
Dehydration kinetics of neotame monohydrate.
Zedong Dong
,
Jonathon S. Salsbury
,
+6 authors
D. Grant
Journal of Pharmacy and Science
2002
Corpus ID: 24134974
The dehydration of neotame monohydrate was monitored at various temperatures by differential scanning calorimetry (DSC…
Expand
2002
2002
Neotame Anhydrate Polymorphs II: Quantitation and Relative Physical Stability
Zedong Dong
,
E. Munson
,
S. Schroeder
,
I. Prakash
,
D. Grant
Pharmaceutical Research
2002
Corpus ID: 1858788
AbstractPurpose. To study the relative thermodynamic and kinetic stabilities of neotame anhydrate polymorphs A, D, F, and G, and…
Expand
2002
2002
Neotame Anhydrate Polymorphs I: Preparation and Characterization
Zedong Dong
,
B. Padden
,
+4 authors
D. Grant
Pharmaceutical Research
2002
Corpus ID: 13197501
AbstractPurpose: To prepare, characterize, and compare polymorphs of neotame anhydrate. Methods: Neotame anhydrate polymorphs…
Expand
2002
2002
Conformational flexibility and hydrogen-bonding patterns of the neotame molecule in its various solid forms.
Zedong Dong
,
E. Munson
,
S. Schroeder
,
I. Prakash
,
D. Grant
Journal of Pharmacy and Science
2002
Corpus ID: 22348297
The conformational flexibility and the molecular packing patterns of the neotame molecule in its various crystal forms, including…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE